Valuation: ViaDerma, Inc.

Market Cap 6.31M 5.51M 5.08M 4.69M 8.83M 607M 9.03M 60.78M 23.91M 297M 23.68M 23.16M 1.02B P/E 2015
10.7x
P/E 2016 -3.3x
Enterprise Value 6.6M 5.77M 5.32M 4.91M 9.25M 636M 9.46M 63.64M 25.03M 311M 24.8M 24.25M 1.07B EV / Sales 2015
1.5x
EV / Sales 2016 3.63x
Free-Float
99%
Yield 2015 *
-
Yield 2016 -
Manager TitleAgeSince
Chief Executive Officer - 30/03/2014
Director TitleAgeSince
Chairman - 30/03/2014
Change 5-day change 1-year change 3-year change Capi.($)
+5.85%-24.07% - - 493K
-1.29%-3.11%-0.35%+2.64% 49.18B
+3.90%-0.39%+386.06%+588.97% 39.58B
-1.70%+4.46%+5.93%+61.54% 34.69B
-2.01%-0.76%+28.41%-8.52% 34.42B
+0.06%+0.34%+2.38%+34.47% 27.11B
+0.46%-3.49% - - 16.21B
-0.04%-0.09%+72.42%+116.45% 15.36B
+1.12%+1.91%+14.54%+15.44% 14.05B
0.00%+1.36%+18.43%-31.23% 13.02B
Average +0.63%+0.03%+65.98%+97.47% 27.07B
Weighted average by Cap. -0.05%-0.18%+79.44%+122.31%

Financials

2015 2016
Net sales 192K 168K 155K 143K 269K 18.47M 275K 1.85M 727K 9.05M 720K 704K 31.14M 252K 220K 203K 187K 353K 24.27M 361K 2.43M 955K 11.88M 946K 926K 40.91M
Net income 27.12K 23.7K 21.87K 20.16K 38K 2.61M 38.84K 261K 103K 1.28M 102K 99.62K 4.4M -122K -106K -98.23K -90.54K -171K -11.73M -174K -1.17M -462K -5.74M -457K -447K -19.78M
Net Debt 288K 252K 232K 214K 404K 27.76M 413K 2.78M 1.09M 13.59M 1.08M 1.06M 46.8M 297K 259K 239K 221K 416K 28.58M 425K 2.86M 1.13M 14M 1.11M 1.09M 48.19M
Logo ViaDerma, Inc.
ViaDerma, Inc. is a pharmaceutical company. The Company is engaged in the manufacture and sale of pharmaceutical related products in the United States of America. The Company’s lead product is a topical antibiotic, which is focused on being sold under the brand name Vitastem. The Company also has products in development in the fields: anti-aging skin care, pain management, hair-loss, and toenail fungus. Its products are based on a patent-pending delivery system technology that allows for rapid mass transfer of the pharmaceutical active ingredient across the skin and into the body to provide immediate localized therapy. The Company utilizes a specific trade secret formulation system in the manufacture of all products. The Company’s products are sold to local medical practitioners and patients in clinics primarily in the Los Angeles, California area. The Company’s subsidiary is ViaDerma, II Inc.
Employees
-